Skip to main content
Kim Smith-Whitley, MD, Pediatric Hematology & Oncology, Philadelphia, PA

KimMSmith-WhitleyMD

Pediatric Hematology & Oncology Philadelphia, PA

Associate Professor, Pediatrics, Perelman School of Medicine

Dr. Smith-Whitley is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Smith-Whitley's full profile

Already have an account?

  • Office

    3401 Civic Center Blvd
    # Children
    Philadelphia, PA 19104
    Phone+1 215-590-3535
    Fax+1 215-590-3992

Education & Training

  • Children's Hospital of Philadelphia
    Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 1992 - 1995
  • Children's National Hospital
    Children's National HospitalResidency, Pediatrics, 1989 - 1992
  • George Washington University School of Medicine and Health Sciences
    George Washington University School of Medicine and Health SciencesClass of 1989

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 1992 - 2024
  • American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Clinical Practice Patterns for Hydroxyurea Initiation in Young Children with Sickle Cell Disease
    Kim Smith-Whitley, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Crizanlizumab 5.0 Mg/Kg Exhibits a Favorable Safety Profile in Patients with Sickle Cell Disease: Pooled Data from Two Phase II Studies
    Kim Smith-Whitley, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • 2'-O-Methoxyethyl Splice-Switching Oligos to Reverse Splicing from IVS2-745 _-Thalassemia Patient Cells: A Foundation for Potential Therapies
    Kim Smith-Whitley, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Join now to see all

Lectures

  • Management of Sickle Cell Disease Complications Beyond Acute Chest 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Featured Topic: Sickle Cell Disease: New Drugs, Curative Approaches 
    60th American Society of Hematology Annual Meeting - 12/3/2018

Authored Content

  • For People with Sickle Cell Disease, Add Check-Ins to CheckupsOctober 2021

Press Mentions

  • GBT and Sickle Cell Disease Association of America to Host 11th Annual Sickle Cell Disease Therapeutics Conference
    GBT and Sickle Cell Disease Association of America to Host 11th Annual Sickle Cell Disease Therapeutics ConferenceSeptember 8th, 2022
  • GBT Announces Five Data Presentations on Sickle Cell Disease at Upcoming EHA2022 Congress
    GBT Announces Five Data Presentations on Sickle Cell Disease at Upcoming EHA2022 CongressMay 12th, 2022
  • Global Blood Therapeutics (GBT) Q1 2022 Earnings Call Transcript
    Global Blood Therapeutics (GBT) Q1 2022 Earnings Call TranscriptMay 4th, 2022
  • Join now to see all